Literature DB >> 24961831

From bedside to bench--reverse translational medicine. Scientific lessons from revertant mosaicism in 'knockout' humans.

Andreas Recke1, Ralf J Ludwig.   

Abstract

While the transition from basic life science research to clinical applications is often much more cumbersome than promised, Gostyński et al. took the opposite approach and demonstrated how a scholarly, biology-guided perspective on human skin disease can reveal basic principles of human biology. Hereditary blistering diseases represent not only a disastrous fate for affected patients, but also an opportunity for understanding human molecular physiology and pathophysiology. On the basis of their clinical expertise, Gostyński et al. have elegantly used differences between lesional and non-lesional as a unique opportunity to dissect the role of structural skin proteins--namely type XVII collagen, laminin β3 and type VII collagen--in melanocyte biology, thus elucidating a new concept in melanocyte biology by transferring knowledge in reverse direction from bedside to bench.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bullous pemphigoid; melanocyte; melanoma; skin; type XVII collagen

Mesh:

Substances:

Year:  2014        PMID: 24961831     DOI: 10.1111/exd.12475

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  2 in total

1.  Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits.

Authors:  Péter Hegyi; Ole H Petersen; Stephen Holgate; Bálint Erőss; András Garami; Zsolt Szakács; Dalma Dobszai; Márta Balaskó; Lajos Kemény; Shuang Peng; Joao Monteiro; András Varró; Tara Lamont; Jeffrey Laurence; Zoe Gray; Andrew Pickles; Garret A FitzGerald; Christopher E M Griffiths; Jacek Jassem; Dmitri A Rusakov; Alexei Verkhratsky; Andrea Szentesi
Journal:  J Clin Med       Date:  2020-05-19       Impact factor: 4.241

2.  Transforming Translation: Impact of Clinical and Translational Science.

Authors:  J A Wagner; D L Kroetz
Journal:  Clin Transl Sci       Date:  2016-01-15       Impact factor: 4.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.